Burden on Oncologists When Communicating the Discontinuation of Anticancer Treatment

OBJECTIVE: Communicating the discontinuation of anticancer treatment to patients is a difficult task. The primary aim of this study was to clarify the level of oncologist-reported burden when communicating about discontinuation of an anticancer treatment. The secondary aims were (i) to identify the...

Descripción completa

Detalles Bibliográficos
Autores principales: Otani, Hiroyuki, Morita, Tatsuya, Esaki, Taito, Ariyama, Hiroshi, Tsukasa, Koichiro, Oshima, Akira, Shiraisi, Keiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146312/
https://www.ncbi.nlm.nih.gov/pubmed/21764830
http://dx.doi.org/10.1093/jjco/hyr092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146312/
https://www.ncbi.nlm.nih.gov/pubmed/21764830
http://dx.doi.org/10.1093/jjco/hyr092

Ejemplares similares